University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana
London: The R21/Matrix-M malaria vaccine, developed by the University of Oxford, leveraging an adjuvant technology from Novavax, and manufactured and scaled up by the Serum Institute of India Pvt Ltd (SIIPL), has been granted full national licensure for use in Ghana by the country’s Food and Drugs Authority (FDA Ghana). This marks the first regulatory […] More